These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1125 related items for PubMed ID: 15324513

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A short-term cost-of-treatment model for type 2 diabetes: comparison of glipizide gastrointestinal therapeutic system, metformin, and acarbose.
    Ramsdell JW, Grossman JA, Stephens JM, Botteman MF, Arocho R.
    Am J Manag Care; 1999 Aug; 5(8):1007-24. PubMed ID: 10558125
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States.
    Pollock RF, Curtis BH, Valentine WJ.
    J Med Econ; 2012 Aug; 15(4):766-75. PubMed ID: 22413830
    [Abstract] [Full Text] [Related]

  • 30. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care.
    Killilea T.
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S441-9. PubMed ID: 12408407
    [Abstract] [Full Text] [Related]

  • 31. Cost-effectiveness of use of the GlucoWatch Biographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomized controlled trial.
    Eastman RC, Leptien AD, Chase HP.
    Pediatr Diabetes; 2003 Jun; 4(2):82-6. PubMed ID: 14655264
    [Abstract] [Full Text] [Related]

  • 32. Diabetes in the 1990s--an overview.
    Jiwa F.
    Stat Bull Metrop Insur Co; 1997 Jun; 78(1):2-8. PubMed ID: 9029704
    [Abstract] [Full Text] [Related]

  • 33. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
    Ringborg A, Yin DD, Martinell M, Stålhammar J, Lindgren P.
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
    [Abstract] [Full Text] [Related]

  • 34. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J, Halinan S, Hines D, Delozier A, Perez M, Boye M, Boye KS, Blanchette CM.
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [Abstract] [Full Text] [Related]

  • 35. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X, Zhang P, Hoerger TJ.
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [Abstract] [Full Text] [Related]

  • 36. Improving quality of care in people with Type 2 diabetes through the Associazione Medici Diabetologi-annals initiative: a long-term cost-effectiveness analysis.
    Giorda CB, Nicolucci A, Pellegrini F, Kristiansen CK, Hunt B, Valentine WJ, Vespasiani G.
    Diabet Med; 2014 May; 31(5):615-23. PubMed ID: 24246087
    [Abstract] [Full Text] [Related]

  • 37. Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
    Palmer AJ, Roze S, Lammert M, Valentine WJ, Minshall ME, Nicklasson L, Gall MA, Spinas GA.
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S41-51. PubMed ID: 15324515
    [Abstract] [Full Text] [Related]

  • 38. The uses of outcomes research for medical effectiveness, quality of care, and reimbursement in type II diabetes.
    Greenfield S, Kaplan SH, Silliman RA, Sullivan L, Manning W, D'Agostino R, Singer DE, Nathan DM.
    Diabetes Care; 1994 Jun; 17 Suppl 1():32-9. PubMed ID: 8088221
    [Abstract] [Full Text] [Related]

  • 39. Lifetime health effects and costs of diabetes treatment.
    Niessen LW, Dijkstra R, Hutubessy R, Rutten GE, Casparie AF.
    Neth J Med; 2003 Nov; 61(11):355-64. PubMed ID: 14768718
    [Abstract] [Full Text] [Related]

  • 40. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach.
    Bolin K, Gip C, Mörk AC, Lindgren B.
    Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.